We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.38B
AUM Growth
+$16.2M
Cap. Flow
-$65.9M
Cap. Flow %
-2.78%
Top 10 Hldgs %
48.01%
Holding
72
New
8
Increased
36
Reduced
21
Closed
6

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$33M
2
MDVN
MEDIVATION, INC.
MDVN
+$27.8M
3
PFE icon
Pfizer
PFE
+$24.4M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.8M
5
AGN
Allergan Inc
AGN
+$13.6M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$71.4M
2
ILMN icon
Illumina
ILMN
+$44.1M
3
SHPG
Shire pic
SHPG
+$39.5M
4
MRK icon
Merck
MRK
+$37.9M
5
GILD icon
Gilead Sciences
GILD
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 89.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGNT
26
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$32M 1.35%
1,029,472
-29,834
-3% -$808K
ABBV icon
27
AbbVie
ABBV
$460B
$25.7M 1.08%
444,107
+172,366
+63% +$9.57M
PFE icon
28
Pfizer
PFE
$141B
$24.4M 1.03%
+868,442
New +$24.4M
MNTA
29
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$24.2M 1.02%
2,134,440
+460,300
+27% +$5.25M
IMGN
30
DELISTED
Immunogen Inc
IMGN
$24M 1.01%
2,269,597
-948,679
-29% -$10.7M
UTHR icon
31
United Therapeutics
UTHR
$26.5B
$23.5M 0.99%
182,400
– –
CMRX
32
DELISTED
Chimerix, Inc.
CMRX
$23.3M 0.98%
842,149
+210,255
+33% +$5.1M
SGEN
33
DELISTED
Seagen Inc. Common Stock
SGEN
$22.7M 0.95%
609,819
-2,400
-0.4% -$94.4K
XLRN
34
DELISTED
Acceleron Pharma
XLRN
$22M 0.92%
726,424
+137,371
+23% +$3.87M
INSM icon
35
Insmed
INSM
$23.1B
$21.2M 0.89%
1,625,323
-360,415
-18% -$5.44M
AKRX
36
DELISTED
Akorn Inc
AKRX
$21.2M 0.89%
584,643
-175,000
-23% -$6.27M
COV
37
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$20.1M 0.85%
232,358
+13,936
+6% +$1.23M
SHPG
38
DELISTED
Shire pic
SHPG
$18.5M 0.78%
71,536
-159,100
-69% -$39.5M
ICPT
39
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$18.4M 0.78%
77,893
+3,900
+5% +$994K
ISRG icon
40
Intuitive Surgical
ISRG
$127B
$17.3M 0.73%
337,284
-13,563
-4% -$673K
KPTI icon
41
Karyopharm Therapeutics
KPTI
$172M
$17.1M 0.72%
32,556
+14,653
+82% +$8.27M
INVA icon
42
Innoviva
INVA
$1.6B
$16.6M 0.7%
971,438
-771,750
-44% -$17.7M
RLYP
43
DELISTED
RELYPSA INC COM
RLYP
$15.6M 0.66%
738,573
+25,600
+4% +$621K
ALGN icon
44
Align Technology
ALGN
$12.1B
$13.9M 0.58%
268,360
-25,996
-9% -$1.42M
BHC icon
45
Bausch Health
BHC
$1.69B
$12.5M 0.53%
95,400
-73,500
-44% -$8.76M
BSX icon
46
Boston Scientific
BSX
$68.4B
$12.4M 0.52%
1,047,166
+3,579
+0.3% +$45.1K
NXTM
47
DELISTED
NxStage Medical Inc.
NXTM
$11.6M 0.49%
881,732
+386,176
+78% +$5.2M
TRNX
48
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$11.2M 0.47%
469,023
-8,806
-2% -$197K
DXCM icon
49
DexCom
DXCM
$28.5B
$11M 0.46%
1,105,064
-44,820
-4% -$458K
HTWR
50
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$10.8M 0.45%
138,849
+17,722
+15% +$1.47M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sectoral Asset Management held 72 positions worth $2.38B, up 0.69% from $2.36B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management's Q3 2014 filing shows 8 new, 36 increased, 21 reduced and 6 closed positions. Its largest new stake was Pfizer: 868,442 shares worth $24.4M. The largest sale was Vertex Pharmaceuticals, an estimated $71.4M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier.

  • Sectoral Asset Management's largest Q3 2014 buy was Pfizer: 868,442 shares worth $24.4M.
  • Sectoral Asset Management added most to Viatris in Q3 2014, an estimated $33M increase.
  • Sectoral Asset Management's biggest Q3 2014 reduction was Vertex Pharmaceuticals, cutting an estimated $71.4M.
  • Sectoral Asset Management fully exited Illumina in Q3 2014, selling an estimated $44.1M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $2.38B portfolio in Q3 2014.
  • Sectoral Asset Management opened 8 new positions and closed 6 in Q3 2014.
  • Sectoral Asset Management's portfolio value rose 0.69% quarter-over-quarter to $2.38B.

Based on Sectoral Asset Management's 13F filing for Q3 2014, filed 13 Nov 2014.